Mnd Promoter Chimeric Antigen Receptors

Patent No. EP3689899 (titled "Mnd Promoter Chimeric Antigen Receptors") was filed by Bluebird BIO on Apr 24, 2015. The application was issued on Nov 24, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BOULT WADE TENNANTJul 13, 2022BOULT WADE TENNANT

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3689899

BLUEBIRD BIO
Application Number
EP19218258A
Filing Date
Apr 24, 2015
Status
Revoked
Jun 21, 2025
Publication Date
Nov 24, 2021